Literature DB >> 22467722

Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.

A U Wells, J Behr, U Costabel, V Cottin, V Poletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22467722     DOI： 10.1183/09031936.00009112

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

Review 1.  Promising new treatment targets in patients with fibrosing lung disorders.

Authors:  Martina Sterclova; Martina Vasakova
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

2.  Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.

Authors:  Yael Aschner; Meghan Nelson; Matthew Brenner; Helen Roybal; Keriann Beke; Carly Meador; Daniel Foster; Kelly A Correll; Paul R Reynolds; Kelsey Anderson; Elizabeth F Redente; Jennifer Matsuda; David W H Riches; Steve D Groshong; Ambra Pozzi; Jan Sap; Qin Wang; Dhaarmini Rajshankar; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-03       Impact factor: 5.464

Review 3.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

Review 4.  The Witschi Hypothesis revisited after 35 years: genetic proof from SP-C BRICHOS domain mutations.

Authors:  Bruce D Uhal; Hang Nguyen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

5.  Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Authors:  Jürgen Behr; Michael Kreuter; Marius M Hoeper; Hubert Wirtz; Jens Klotsche; Dirk Koschel; Stefan Andreas; Martin Claussen; Christian Grohé; Henrike Wilkens; Winfried Randerath; Dirk Skowasch; F Joachim Meyer; Joachim Kirschner; Sven Gläser; Felix J F Herth; Tobias Welte; Rudolf Maria Huber; Claus Neurohr; Martin Schwaiblmair; Martin Kohlhäufl; Gert Höffken; Matthias Held; Andrea Koch; Thomas Bahmer; David Pittrow
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

6.  Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experience.

Authors:  Somenath Kundu; Subhra Mitra; Joydeep Ganguly; Subhasis Mukherjee; Souvik Ray; Ritabrata Mitra
Journal:  Lung India       Date:  2014-10

Review 7.  Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Authors:  Tong Sun; Jing Liu; De Wei Zhao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.

Authors:  Ayodeji Adegunsoye; Cara L Hrusch; Catherine A Bonham; Mohammad R Jaffery; Kelly M Blaine; Meghan Sullivan; Matthew M Churpek; Mary E Strek; Imre Noth; Anne I Sperling
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

9.  Where do we stand with IPF treatment?

Authors:  C Albera; C Ferrero; E Rindone; S Zanotto; E Rizza
Journal:  Respir Res       Date:  2013-04-16

10.  Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.

Authors:  Vincent Cottin
Journal:  BMC Res Notes       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.